Inflammation in COVID-19: from pathogenesis to treatment

Area of Science:

• Immunology
• Infectious Diseases
• Pathophysiology

Background:

• Coronavirus disease 2019 (COVID-19) became a global pandemic in March 2020.
• Over 163 million cases and 3.3 million deaths have been reported worldwide.
• Inflammation is a critical factor in COVID-19 pathogenesis, with overwhelming inflammation linked to poor prognosis.

Purpose of the Study:

• To provide an overview of inflammation's role in COVID-19.
• To critically evaluate immunomodulatory and anti-inflammatory treatment strategies for COVID-19.
• To summarize key findings from existing research on COVID-19 inflammation and treatments.

Main Methods:

• Literature review of scientific studies on COVID-19, inflammation, and immune system targeting therapies.
• Critical analysis of therapeutic approaches and their efficacy.
• Synthesis of current knowledge on the subject.

Main Results:

• Inflammation plays a central role in the severity and outcomes of COVID-19.
• Various therapeutic strategies targeting the immune system and inflammation are under investigation.
• Numerous studies have explored these approaches, yielding significant insights.

Conclusions:

• Understanding the inflammatory processes in COVID-19 is crucial for developing effective treatments.
• Targeting inflammation and the immune response holds promise for managing severe COVID-19.
• Continued research is essential to refine therapeutic strategies and improve patient outcomes.